Press release
Analysis of Potential Impact of COVID-19 on Compounding Pharmacy Market
Compounding is the science of combining and preparing personalized medicines for patients. These medications are prepared based on the practitioner’s prescription wherein, the individual ingredients are mixed together as per the suggested dosage form, and strength.View Report : https://www.transparencymarketresearch.com/compounding-pharmacy-market.html
The trained pharmacists are approved to personalize the medicine for the patient meeting their specific needs such as strengths, dosage forms, flavors, and exclusion of ingredients for which the patient is allergic or sensitive. However, compounded drugs are not FDA approved, indicating that FDA does not inspect the safety and the effectiveness of these drugs. This responsibility is held by the state boards of pharmacy, who verify that the state-licensed pharmacies manufacture compound drugs comply with conditions of section 503A of the FDCA. For the purpose of inspection, compounding pharmacies are segmented into sterile and non-sterile facilities.
Get Brochure of the Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=25310
The growing patent expiries is one of the primary growth driving factor in the compounding pharmacy market. The shortage of drugs in the U.S. as reported by the U.S. FDA and also the similar shortages globally; the various advantages of compounding drugs such as the customization according to the patients’ needs contribute to the growth of the market. However, lack of efficient regulations in place in various regions, might lead to adulterated drugs being sold in the market, which might negatively impact the market.
The compounding pharmacy market can be segmented on the basis of product type, therapeutic area, distribution channel, and region. On the basis of product type, the compounding pharmacy market can be segmented into oral medications, topical medications, suppositories, and others.
The oral medications can be further segmented into capsules, tablets, suspensions, lozenges, and others. The topical medications can be further segmented into creams, gels, ointments, and others. On the basis of therapeutic area, the market can be segmented into pain medications, hormone replacement therapies, dermatological applications, and others.
Request For Covid19 Impact Analysis – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=25310
On the basis of distribution channel, the market can be segmented into compounding pharmacies, and traditional stores. On the basis of product type, topical medications are anticipated to record significant growth in the forecast period, owing to the growing demand for dermatological applications and rising market for hormone replacement therapies. Hormone replacement therapy is anticipated to be the growing application in the forecast period, owing to their growing application in the treatment of various diseases such as cancer, and also in maintaining the hormonal levels in menopause. On the basis of distribution channel, compounding pharmacy stores which are approved by state regulatory bodies are anticipated to record robust growth in the forecast period.
Buy Now Report : https://www.transparencymarketresearch.com/checkout.php?rep_id=25310<ype=S
Geographically, the market can be segmented into five regions, including North America, Latin America, Asia Pacific, Europe, and Middle East & Africa. North America was the leading region in the compounding pharmacy market. It is anticipated to be the highest revenue contributor in the forecast period. The growth can be attributed to the shortage of drugs reported by the FDA in the U.S. Europe in anticipated to be trailing next region in terms of revenue contribution to the market. Asia Pacific is anticipated to record highest CAGR growth in the forecast period. This growth can be attributed to the growing pharmaceutical awareness among people, increasing geriatric population, and expansion of infrastructural facilities, among others. The growth in Asia Pacific is expected to be driven by India, and China among other countries.
Read our Case study at : https://www.transparencymarketresearch.com/casestudies/innovative-medical-device-manufacturing-start-up
The leading players in the compounding pharmacy market include Fagron, Compounding Pharmacies, Institutional Pharmacy Solutions, B. Braun Melsungen AG Company, Cantrell Drug Company, PharMEDium Services LLC, Triangle Lorraine’s Pharmacy, and Fresenius Kabi AG., among others.
More Trending Reports by Transparency Market Research – 1. https://www.prnewswire.com/news-releases/global-fish-collagen-peptides-market-to-clock-cagr-of–8-from-2019-to-2027-application-in-cosmeceuticals-major-source-of-revenue-transparency-market-research-301006442.html
2. https://www.biospace.com/article/atopic-dermatitis-drugs-market-exponential-growth-of-biologic-drugs-favor-market-growth/
Contact
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.”
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Analysis of Potential Impact of COVID-19 on Compounding Pharmacy Market here
News-ID: 2158916 • Views: …
More Releases from Transparency Market Research
Aviation Lubricants Market Outlook 2031: Global Value to Reach USD 1.6 Billion D …
The aviation lubricants market is entering a phase of steady expansion, backed by consistent growth in global air traffic, increasing air cargo activities, and the rising emphasis on sustainable aviation operations. Valued at US$ 991.8 Mn in 2022, the global market is projected to reach US$ 1.6 Bn by 2031, expanding at a CAGR of 5.4% between 2023 and 2031. This growth trajectory highlights significant industry transformation driven by synthetic…
Aviation Lubricants Market Outlook 2031: Global Value to Reach USD 1.6 Billion D …
The aviation lubricants market is entering a phase of steady expansion, backed by consistent growth in global air traffic, increasing air cargo activities, and the rising emphasis on sustainable aviation operations. Valued at US$ 991.8 Mn in 2022, the global market is projected to reach US$ 1.6 Bn by 2031, expanding at a CAGR of 5.4% between 2023 and 2031. This growth trajectory highlights significant industry transformation driven by synthetic…
Truck Mounted Concrete Pump Market Outlook 2031: Global Market to Reach USD 3.8 …
The global truck mounted concrete pump market, valued at US$ 2.8 Bn in 2022, is witnessing steady and sustained growth as infrastructure development accelerates across the world. According to market projections, the industry is expected to reach US$ 3.8 Bn by 2031, expanding at a CAGR of 3.6% between 2023 and 2031. This growth is supported by large-scale urbanization, expanded commercial construction, rising investment in megaprojects, and increasing adoption of…
Global Specialty Silica Market Poised to Reach USD 13.8 Billion by 2031 Amid Ris …
The global Specialty Silica Market continues its strong upward trajectory, driven by advancements in automotive, rubber, plastics, personal care, and coatings industries. According to the latest industry outlook, the market valued at USD 7.4 billion in 2022 is expected to grow at a CAGR of 7.3% from 2023 to 2031, reaching USD 13.8 billion by 2031. Continuous innovations, rising sustainability initiatives, and increased demand for high-performance materials are shaping the…
More Releases for FDA
DreaMed receives 5th FDA Clearance
TEL AVIV, Israel: DreaMed Diabetes LTD. ("DreaMed" or the "Company"), developer of the endo.digital Clinical Decision Support System announced today that it has received its 5th U.S Food and Drug Administration (FDA) clearance that expands the scope of AI enhanced treatment recommendations to patients on fixed meal insulin regimens. endo.digital is the first decision support system that has been cleared to assist healthcare providers in the management of diabetes…
FDA Compliant Blood Storage and Preservation
Accsense Monitoring System Automates Data Archive and Alarming
CAS DataLoggers provided the temperature alarming and monitoring system to a hospital blood bank looking to replace their old paper chart recorders as they became unreliable and spare parts were harder to find. For proper blood storage and preservation, the lab’s medical units needed to maintain storage temperatures between 2°C to 6°C (36°F to 43°F), given the perishability of blood components. The facility…
FDA grants orphan drug status to Vicore
US Food and Drug Administration has awarded Vicore Pharmaceuticals with orphan Drug designation for the treatment of Idiopathic Pulmonary Fibrosis (IPF). FDA’s Orphan Drug Designation program provides certain incentives for companies developing therapeutics to treat rare diseases or conditions, defined as those affecting less than 200,000 individuals in the U.S. A drug candidate and its sponsor must meet several key criteria in order to qualify for, and obtain, orphan drug…
New FDA Design Control Training Courses
Salt Lake City, Utah - February 23 2017 - Procenius Consulting is a medical device consulting firm specializing solely in medical device design controls regulation (21 CFR 820.30).
Announcing New Design Control Training Courses
Procenius Consulting has just launched two new training courses covering basic and advanced topics of medical device design control regulation. These courses focus on compliance, practical implementation and industry best practices techniques for developing or improving a…
fda online training
GRC Training Solutions provides end-to-end FDA compliance solutions for those companies who want to maximize security, minimize operational costs, improve staff productivity and stay on top of all their compliance documentation.
GRC Training Solutions boasts a team of experts and specialists who have a proven track record in working with the biotechnology, medical device, diagnostic and pharmaceutical fields. Our team will work with you closely and develop solutions that meet…
FDA online training
Description:
Device firms, establishments or facilities that are involved in the production and distribution of medical devices intended for use in the U.S are required to register annually. Most establishments that are required to register with the FDA are also required to list the devices that are made there and the activities that are performed on those devices. Initially, FDA issued a 28-page Proposed Rule that would amend its regulations regarding…
